| 发明名称 |
PHARMACEUTICAL FORMULATION |
| 摘要 |
The present invention provides enteric polymer coated tablet formulations for oral administration which comprise a phospholipase A2 enzyme Lipoprotein Associated Phospholipase A2 (Lp-PLA2) inhibitor, processes for preparing such formulations and their use in therapy, in particular the treatment of atherosclerosis.
|
| 申请公布号 |
US2009306113(A1) |
申请公布日期 |
2009.12.10 |
| 申请号 |
US20090478934 |
申请日期 |
2009.06.05 |
| 申请人 |
VAN SCHIE DIRK MARINUS JOHANNES |
发明人 |
VAN SCHIE DIRK MARINUS JOHANNES |
| 分类号 |
A61K31/505;A61K9/20;A61K9/28;A61K9/30;A61K9/56;A61K31/513;A61P9/10;A61P43/00 |
主分类号 |
A61K31/505 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
